Chemed Corporation (CHE)
Health Care · Diversified Services and Healthcare · NYSE
Chemed Corporation is a diversified provider of hospice and palliative care services via VITAS Healthcare and professional plumbing and drain cleaning services through Roto-Rooter.
What Chemed Corporation does
Chemed Corporation operates through two primary business segments: VITAS Healthcare, which is a provider of end-of-life hospice care, and Roto-Rooter, which offers plumbing and drain cleaning services. VITAS provides hospice services in various states across the U.S., while Roto-Rooter provides residential and commercial plumbing services.
Themes: hospice care, palliative care, home services, plumbing and drain cleaning
Fundamentals
- Price$499.82 as of 2026-10-09 close
- Market cap$6.5B as of 2026-06-30 (share count; price 2026-10-09)
- 1-year return+15.9% 2025-10-09 close $431.41 → 2026-10-09 close $499.82
- P/E25.09 as of 2026-10-09
- Net margin+10.5% FY2025, SEC XBRL
- ROE+27.1% FY2025, SEC XBRL
- Debt / equity0.21 as of 2026-09-03
- Revenue growth (YoY)+3.3% as of 2026-09-03
- Revenue CAGR (3y)+5.8% SEC XBRL
- Beta0.22 as of 2026-09-03
- Last reported earnings2026-07-28 SEC EDGAR Form 8-K (Item 2.02)
Dividend: yield +0.6%; at least 18 years of non-decreasing per-share dividends (SEC XBRL) — we do not hold the year before it, so the real streak may be longer.
How CHE compares in its sector
- price-to-earnings ratiomiddle range 185 covered Health Care peers, as of 2026-10-09
- net profit margintop 25% 430 covered Health Care peers, as of 2026-09-03
- operating margintop 25% 417 covered Health Care peers, as of 2026-09-03
- return on equitytop 10% 510 covered Health Care peers, as of 2026-09-03
- 3-year revenue CAGRmiddle range 402 covered Health Care peers
- indicated dividend yieldbottom 25% 72 covered Health Care peers, as of 2026-09-03
- free cash flow (absolute dollars, latest fiscal year)top 25% 494 covered Health Care peers, as of FY2025
Position among covered Health Care companies that report each metric (minimum 5 peers). A relative position within our covered catalog — not a valuation, quality, or investment judgment. A higher percentile is simply a higher value (for P/E, more expensive on earnings — never "better"). Informational only.
Top 10 scores & list membership
CHE is not currently in any published Top 10 list. Its scores are below.
Top 10 score
59.4 #250 of 1,383 scored · #31 of 153 in Health Care
Capital return 92nd (consecutive years of dividend increases 18 years, net share count bought back over the year 4.8) and profitability 70th (return on equity 27.1%, operating margin 13.4%); weakest is growth (35th, revenue growth year over year 3.3%, 3-year revenue CAGR 5.8%).
Scores as of 9 Oct 2026. Each bar is a percentile: how this company ranked against every company the score ranked, 0–100. A list is a published formula and its output, not a recommendation. Method version 4.
Dividend coverage (FY2025)
Covered by reported results. In FY2025, CHE's dividend was covered by reported results (earnings payout 12%, free-cash-flow payout 10%). This describes past coverage, not a forecast.
- Earnings payout12% dividends / net income
- Free-cash-flow payout10% dividends / (operating cash flow − capex)
Coverage derived from reported SEC EDGAR XBRL figures for FY2025 (dividends paid vs. net income and free cash flow, same fiscal year). This describes PAST coverage for one fiscal year — it does not predict whether a dividend will be maintained, raised, or cut, and a one-year payout ratio can be distorted by non-recurring items. Informational only — not financial advice.
How Chemed Corporation looks technically
Chemed Corporation (CHE) is trading 9.4% above its 200-day average, the long-term trend line — a longer-term uptrend. Its 50-day average crossed above its 200-day average about 69 trading days ago — a "golden cross", a bullish long-term signal. There is no clear trend right now — the price is choppy (ADX, a 0–100 trend-strength gauge, is 11, below the 25 that marks a real trend). Momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 42, neither overbought (above 70) nor oversold (below 30). MACD, a trend-momentum gauge, turned bearish about 1 trading day ago (its momentum flipped negative). It made a new 20-day low about 12 trading days ago. Day-to-day price swings are unusually narrow versus its own recent history — a "Bollinger squeeze" (in the tightest 1% of the past ~6 months), which often precedes a bigger move.
Trend
8
| Distance from the 200-day | it is trading 9.4% above its 200-day average, the long-term trend line — a longer-term uptrend | +9.4% |
|---|---|---|
| 50-day moving average | its average price over the last 50 trading days — a short-term trend line — is $521.54 | $521.54 |
| 200-day moving average | its average price over the last 200 trading days — the long-term trend line — is $456.91 | $456.91 |
| Swing structure | each recent peak has been lower than the one before it and each dip deeper — the pattern chart-watchers call a downtrend, which describes where price has already been and not where it goes next | lower highs and lower lows |
| Last swing turn | its last significant turn was a swing high 11 calendar days ago — the swings before that are what the structure reading is measured on | 11 sessions |
| Wave structure | its recent swings can be read as a five-part downward sequence — what Elliott-wave chartists call an impulse — now in leg 5 of five; the labelling fails if price closes above 519.05. It is the only labelling that fits, though not with textbook proportions, and it describes the swings already printed, not what comes next. | possible downward five-wave sequence, in wave 5 (atypical proportions) |
| Since the 50/200 cross | its 50-day average crossed above its 200-day average about 69 trading days ago — a "golden cross", a bullish long-term signal | 69 sessions |
| Trend strength (14-day ADX) | there is no clear trend right now — the price is choppy (ADX, a 0–100 trend-strength gauge, is 11, below the 25 that marks a real trend) | 10.5 |
Momentum
3
| 14-day RSI | momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 42, neither overbought (above 70) nor oversold (below 30) | 41.6 |
|---|---|---|
| Position in its 14-day range | it is trading in the lower half of its 14-day range ($491.88 to $519.05) — its "stochastic" reading is 29 out of 100, where 0 would mean closing exactly at the 14-session low and 100 exactly at the high. This measures WHERE the price sits inside its recent range, which is a different question from the RSI beside it: RSI is a momentum gauge, measuring how FAST the price has been moving, so a stock can drift quietly to the bottom of its range with an ordinary RSI, or fall sharply and still sit in the middle. It has been slipping within that range over the last few sessions. | 29.2 |
| Since the MACD crossed zero | MACD, a trend-momentum gauge, turned bearish about 1 trading day ago (its momentum flipped negative) | 1 session |
Range
12
| 52-week high | its highest closing price over the past year (about 252 trading days) was $557.00 | $557.00 |
|---|---|---|
| From the 52-week high | it is 10.3% below its 52-week high (its highest price of the past year) | -10.3% |
| Above the 52-week low | it is 36.8% above its 52-week low (its lowest price of the past year) | +36.9% |
| Below the 52-week high | it is 10.3% below its highest point of the past year | 10.3% |
| Since a 20-day breakout | it made a new 20-day low about 12 trading days ago | 12 sessions |
| Since a 55-day breakout | it made a new 55-day high about 45 trading days ago | 45 sessions |
| All-time high | its highest closing price on record is $654.62 (set on 2024-03-15) | $654.62 |
| Given back of the 52-week move | over the past year its closes ranged ($368.59 to $552.72), and it has given back roughly a quarter of its rise from last year’s low — 29% of it. Chart-watchers call 61.8%-65% given back the "golden pocket" — for this company that is $433.04 to $438.93. It is watched widely enough that orders cluster there, which is the honest reason it matters; it is not a forecast. | 28.7% |
| From the all-time high | it is 23.6% below its all-time high | -23.6% |
| Nearest price level | it is trading 3.8% below a resistance level at $518.85 — a price it turned at six times since 2024-11-04, most recently on 2026-09-28. Since 2024-10-09 it has 6 such levels below the current price and 6 above. Levels like these describe where the price has reversed or paused before; they are not a forecast of where it will go. | +3.8% |
| All-time low | its lowest closing price on record is $29.00 (set on 2008-10-10) | $29.00 |
| Above the all-time low | it is 1623.5% above its all-time low | +1,624% |
Volatility
5
| Band width vs its own 6 months | day-to-day price swings are unusually narrow versus its own recent history — a "Bollinger squeeze" (in the tightest 1% of the past ~6 months), which often precedes a bigger move | 0th percentile |
|---|---|---|
| Typical daily range | in a typical session it travels about $12.17 between its high and its low — about 2.4% of its price. That is its "average true range" over the last 14 sessions, which also counts the distance from the previous close, so a day that opens well away from yesterday counts as the large move it was | $12.17 |
| Bollinger bands (20-day, ±2σ) | most of its recent trading has stayed between about $493.49 and $517.04 — the "Bollinger bands", a range drawn two standard deviations either side of its 20-day average price, which widens when the stock gets more volatile and narrows when it settles | $493.49 – $505.27 – $517.04 |
| Typical daily range (% of price) | its price moves about 2.4% in a typical session — calmer than most companies we cover. This is the average gap between a session's high and low over the last 14 sessions, counting overnight moves, expressed against the current price so it can be compared with companies trading at any price | 2.4% |
| Stretch from the 200-day average | it is trading 3.5 daily ranges above its 200-day average price (9.4% above it in plain percentage terms) — a way of asking how far it has stretched from its own average in units of how far it normally moves in a day, so a calm company and a jumpy one can be compared on the same scale | 3.5 daily ranges above its 200-day average |
Volume
1
| Volume vs its 30-day average | trading volume is about normal versus its 30-day average | 0.85× |
|---|
Analyst
2
| Change in the average price target | analysts' average price target is unchanged from the prior reading | 0.0% |
|---|---|---|
| Change in the consensus rating | the analyst consensus rating is unchanged since the prior reading | unchanged |
Candlestick patterns
3
| Since a doji | 8 sessions ago it opened and closed at almost the same price after trading through a wider range — a "doji", the classic picture of buyers and sellers finishing the session level | 8 sessions ago |
|---|---|---|
| Since a bullish engulfing | 5 sessions ago it opened below the previous session's close and finished above that session's open — a "bullish engulfing" pair, where one up day more than undid the down day before it | 5 sessions ago |
| Since a bearish engulfing | 7 sessions ago it opened above the previous session's close and finished below that session's open — a "bearish engulfing" pair, where one down day more than undid the up day before it | 7 sessions ago |
Price gaps
1
| Gap at the open | it opened on 2026-10-09 0.1% below the previous session's close — an overnight gap, the part of the move that happened while the market was shut, and traded back through that level before the close | -0.1% |
|---|
Price streaks
1
| Closing streak | it closed higher in its latest session, after a session that did not close higher — a single up day rather than a run | 1 session up |
|---|
Relative strength
4
| vs market, 1 month | over the past 1 month this stock lagged the market by 5.7 percentage points (the stock lost 3.6% while the market gained 2.1%) | -5.7% |
|---|---|---|
| vs market, 3 months | over the past 3 months this stock lagged the market by 1.7 percentage points (the stock gained 1.9% while the market gained 3.6%) | -1.7% |
| vs market, 6 months | over the past 6 months this stock beat the market by 13.4 percentage points (the stock gained 27.9% while the market gained 14.5%) | +13.4% |
| vs market, 12 months | over the past 12 months this stock lagged the market by 0.1 percentage points (the stock gained 15.9% while the market gained 16.0%) | -0.1% |
Signal agreement
2
| Bullish technical signals | 3 of the 9 technical signals we can compute for it are currently in a bullish state: a "golden cross" — its 50-day average is above its 200-day, trading above its 200-day average, outperforming the market over 6 months — these describe past price behaviour, not a forecast | 3 of 9 |
|---|---|---|
| Bearish technical signals | 1 of the 9 technical signals we can compute for it is currently in a bearish state: MACD momentum is negative — these describe past price behaviour, not a forecast | 1 of 9 |
Trend (Ichimoku cloud)
1
| Vs the Ichimoku cloud | trading inside the Ichimoku cloud — a band drawn from where its own highs and lows sat up to 2026-09-02 and projected forward over today's price, the zone traders read as unresolved — neither side has established a trend, and the band is where that gets settled. The band itself is moderate, spanning 7.1% of the share price. | 0.0% |
|---|
Volume-weighted price
2
| Vs this year’s average price paid | the price is 11% above the average price paid so far this year, so the typical buyer over that stretch is showing a gain. That average is $449.38 — a volume-weighted average of daily closes over 191 sessions, not a true tick-by-tick VWAP. | +11.2% |
|---|---|---|
| Vs the average paid since it last reported | the price is 4% below the average price paid since it last reported on 2026-07-28 (its 8-K), so the typical buyer over that stretch is under water. That average is $522.00 — a volume-weighted average of daily closes over 53 sessions, not a true tick-by-tick VWAP. | -4.3% |
Price levels it has turned at before
CHE last closed at $499.82 on 2026-10-09. Since 2024-10-09 it has turned at 6 prices below its last close and 6 above; the 3 nearest below and the 3 nearest above are listed, nearest first.
| Level | Side | Distance | Evidence |
|---|---|---|---|
| $518.85 | Resistance | 3.8% above the last close | turned there six times · 2024-11-04 to 2026-09-28 |
| $478.01 | Support | 4.4% below the last close | turned there four times · 2025-07-28 to 2026-02-17 |
| $463.69 | Support | 7.2% below the last close | turned there three times · 2025-08-22 to 2025-09-26 |
| $540.85 | Resistance | 8.2% above the last close | turned there 8 times · 2024-11-19 to 2025-06-09 |
| $456.10 | Support | 8.8% below the last close | turned there three times · 2025-11-12 to 2026-04-24 |
| $554.06 | Resistance | 10.8% above the last close | turned there six times · 2025-04-09 to 2026-08-26 |
A level is a price this company reversed or paused at more than once — they describe past behaviour, not a forecast of where the price will go.
Wave structure
Its recent swings can be read as a five-part downward sequence — what Elliott-wave chartists call an impulse — now in leg 5 of five.
This labelling fails — stops being a possible reading at all — if it closes above $519.05.
It is the only labelling that fits these swings, though its proportions are not the textbook ones. It was chosen from 3 labellings that survived the rules, counting shorter readings of the same bars.
On past moves of this shape the leg has usually ended somewhere between $460.28 and $496.60 — that is where it has tended to end if the count holds, not a forecast of where the price goes.
This reading has stood for 4 trading days, since 2026-10-06.
Read from daily closes as of 2026-10-09.
An Elliott-wave count describes the swings already printed and the level that would disprove it. It is not a forecast, a target, or advice.
Screens: Trading above the 200-day moving average · MACD just crossed bearish (12/26/9) · in a Bollinger Band volatility squeeze · trendless / choppy (low ADX) · beating the market · Under water since its last earnings report (below the anchored VWAP) | Learn: moving average · golden cross · adx · rsi · macd · breakout · bollinger bands
Based on daily closing prices as of 2026-10-09. Describes past price behavior only — informational, not financial advice.
Analyst consensus
- Consensus ratingBuy (2.20 mean, 1=Strong Buy…5=Strong Sell) — 5 analysts
- Mean price target$571.60 range $520.00 – $650.00; median $550.00
Analyst estimates, as of 2026-10-07. These are third-party analyst opinions and price targets, aggregated — not a recommendation, prediction, or advice from stocks-llm. Informational only.
Analyst EPS estimate for CHE
- Consensus EPS estimate$6.44 next reporting period, as of 2026-10-07
- Estimate change, 30 days-$0.04194 (-0.6%) from $6.48, on 2026-09-02, 35-day window
- Readings revised upward13% of 8 comparable readings
The consensus estimate for the next reporting period, and how it has moved between readings of that SAME period. A change is measured only between readings estimating one period — when a company reports, the consensus moves to the next quarter and the two numbers are not comparable. Informational only, not a forecast and not advice.
Key risks (from latest filing)
["Dependence on government reimbursement (Medicare/Medicaid) for hospice services","Regulatory changes in healthcare billing and compliance","Competition in both plumbing and hospice services sectors"]
What changed in the latest 10-Q
AI-assisted comparison of CHE's 10-Q filed 2026-07-31 against the prior one filed 2026-04-28.
Management's Discussion & Analysis (MD&A)
- Added:
- Newer filing adds a summary table with results for the three and six months ended June 30, 2026 and 2025, including service revenues and sales, net income, diluted EPS, adjusted net income, adjusted diluted EPS, adjusted EBITDA, and adjusted EBITDA as a % of revenue figures.
- Newer filing adds revenue analysis for the six months ended June 30, 2026, including a 7.4% increase at VITAS, a 1.1% increase at Roto-Rooter, a 4.2% increase in days-of-care, a 2.5% Medicare reimbursement rate increase, a 120-basis point negative impact from acuity mix shift, and a 190-basis point increase from Medicare Cap and other contra revenue changes.
- Newer filing adds in the balance sheet changes: a $10.3 million increase in prepaid expenses due to prepaid insurance premiums paid in the second quarter.
- Newer filing adds in the balance sheet changes: an $11.4 million increase in lease right of use asset due to lease renewals, with a similar increase in lease liability accounts.
- Newer filing adds in the balance sheet changes: a $20.3 million increase in accounts payable due to timing of payments.
- Newer filing adds in the balance sheet changes: a $10.8 million increase in the liability of deferred compensation plans due mainly to market valuation gains, with a similar increase in associated assets.
- Newer filing adds that as of June 30, 2026, the interest rate on the Credit Agreement is SOFR plus 100 basis points, and that issued standby letters of credit totaled $47.3 million as of June 30, 2026 mainly for insurance purposes.
- Newer filing changes the reference to the Unaudited Consolidated Statements of Cash Flows from singular to plural ("Cash Flows" on page 5).
- Newer filing changes the reconciliation of non-GAAP measures page reference from pages 28-29 to pages 37-39.
- Newer filing changes the typical Federal government payment amount from "in excess of $62.0 million" to "in excess of $63.0 million".
- Newer filing changes the goodwill increase description from "due to the two acquisitions at Roto-Rooter" to "due to four acquisitions at Roto-Rooter" and increases the amount from $20.5 million to $32.4 million.
- Newer filing changes the long-term debt increase amount from $91.2 million to $140.0 million, keeping the reason as primarily acquisitions and stock repurchases.
- Newer filing changes the treasury stock increase amount from $201.1 million to $291.9 million, keeping the reason as stock repurchases.
- Newer filing changes the accounts receivable increase amount from $32.9 million to $6.1 million, keeping the reason as timing of payments.
- Newer filing changes the net cash provided by operating activities comparison from an increase of $55.5 million (March 31, 2025 to March 31, 2026) to an increase of $1.7 million (June 30, 2025 to June 30, 2026).
- Newer filing changes the period-end dates in the Commitments and Contingencies section from March 31, 2026 to June 30, 2026.
- Newer filing updates the standby letters of credit description to state they are as of June 30, 2026 under the Credit Agreement, and removes the corresponding unused lines of credit figure and the sentence about believing liquidity and sources of capital are satisfactory for the foreseeable future.
- Newer filing removes the sentence about being in compliance with financial and debt covenants as of March 31, 2026 under the Prior Credit Agreement and anticipating remaining in compliance throughout the foreseeable future, although the newer text is truncated after "Issued letters of credit re" so this may be incomplete.
- Newer filing removes the income taxes payable balance sheet change of $23.3 million due to timing of payments present in the older filing.
- Newer filing removes the Roto-Rooter Q1 2026 revenue details about a 1.9% decrease in commercial revenue and 1.5% decrease in residential revenue, replacing with Q2 2026 details.
- Newer filing removes the Q1 2026 revenue summary and replaces it with Q2 2026 and six-month summary data.
- Removed:
- Older filing's summary table contains results for the three months ended March 31, 2026 and 2025 only, which are replaced in the newer filing by three and six months ended June 30 data.
- Older filing includes a balance sheet change for a $23.3 million increase in income taxes payable due to timing of payments, which is not present in the newer filing's list.
- Older filing states the typical Federal government payment amount as "in excess of $62.0 million," which is updated to "in excess of $63.0 million" in the newer filing.
- Older filing states the accounts receivable increase was $32.9 million, which is changed to $6.1 million in the newer filing.
- Older filing states the goodwill increase was $20.5 million due to two acquisitions at Roto-Rooter, which is changed to $32.4 million due to four acquisitions in the newer filing.
- Older filing states the long-term debt increase was $91.2 million, which is changed to $140.0 million in the newer filing.
- Older filing states the treasury stock increase was $201.1 million, which is changed to $291.9 million in the newer filing.
- Older filing states net cash provided by operating activities increased $55.5 million from March 31, 2025 to March 31, 2026, which is changed in the newer filing to an increase of $1.7 million from June 30, 2025 to June 30, 2026.
- Older filing includes the sentence: "As of March 31, 2026, we have approximately $313.3 million of unused lines of credit available and are eligible to be drawn down under the Prior Credit Agreement. Management believes its liquidity and sources of capital are satisfactory for the Company's needs in the foreseeable future." This sentence is not present in the newer filing excerpt.
- Older filing includes the statement that the Company was in compliance with all financial and other debt covenants as of March 31, 2026 under the Prior Credit Agreement and anticipated remaining in compliance under the Credit Agreement throughout the foreseeable future. This statement is not present in the newer filing excerpt, though the newer text appears truncated.
- Older filing states issued standby letters of credit as of March 31, 2026 totaled $45.5 million under the Prior Credit Agreement, which continued under the Credit Agreement, mainly for insurance purposes. The newer filing updates this to $47.3 million as of June 30, 2026.
- Older filing references the Unaudited Consolidated Statements of Cash Flow (singular) on page 5, which is changed to "Cash Flows" (plural) in the newer filing.
- Older filing references non-GAAP reconciliation on pages 28-29, which is changed to pages 37-39 in the newer filing.
- Older filing includes Roto-Rooter Q1 2026 revenue decline details (1.9% decrease in commercial revenue and 1.5% decrease in residential revenue), which are not present in the newer filing's Q2 2026 analysis.
- Reworded:
- The Executive Summary's macroeconomic discussion about tariffs, inflation, and the war with Iran is substantially identical in both filings, with no material difference in wording.
- The description of VITAS and Roto-Rooter operations is substantially identical in both filings.
- The statement about liquidity being satisfactory is effectively the same in both filings, though the older filing places it in the Commitments and Contingencies section while the newer filing's excerpt is truncated and may contain a similar statement beyond the cutoff.
- The statement about monitoring macroeconomic trends and uncertainties is substantively unchanged between filings.
- The wording of the Credit Agreement description changes from "The interest on this Credit Agreement has a floating interest rate" to "This Credit Agreement has a floating interest rate," which is a minor wording change.
- The newer filing changes the period reference from March 31, 2026 to June 30, 2026 throughout the Financial Condition and Commitments and Contingencies sections as the reporting period changed.
- The newer filing adds a six-month revenue discussion paragraph that has no counterpart in the older filing.
- Notes:
- The newer filing text appears truncated at the end of the Commitments and Contingencies section ("Issued letters of credit re"), so changes beyond that point cannot be assessed.
- The newer filing contains a stray space in "s ignificant" in the accounts receivable discussion, which is a formatting artifact in the source text and not a substantive change.
- The comparison is limited to the provided MD&A excerpts and does not include any other sections of the filings.
Risk Factors
- Added:
- In the newer filing filed 2026-07-31, the share repurchase table includes additional rows for the second quarter of 2026: April 1 through April 30, 2026, May 1 through May 31, 2026, June 1 through June 30, 2026, and a Second Quarter Total row.
- In the newer filing filed 2026-07-31, the heading for the share repurchase table description states 'for the first six months of 2026' instead of the older filing's 'for the first three months of 2026'.
- Removed:
- In the older filing filed 2026-04-28, the risk factor statement includes the word 'other' in the phrase 'no other material changes', which is not present in the newer filing's phrase 'no material changes'.
- Reworded:
- In the newer filing filed 2026-07-31, the phrase 'Quarterly Report on Form 10-Q' appears capitalized in the risk factor statement, while the older filing filed 2026-04-28 has 'Quarterly Report on form 10-Q' with 'form' in lowercase.
- In the share repurchase table, the older filing filed 2026-04-28 lists the dollar amount remaining under the program as '$229,301,903' for March 1 through March 31, 2026, while the newer filing filed 2026-07-31 lists '$229,601,903' for the same row.
- In Exhibit 101, the older filing filed 2026-04-28 refers to the quarter ended March 31, 2026, while the newer filing filed 2026-07-31 refers to the quarter ended June 30, 2026.
- In Exhibit 104, the older filing filed 2026-04-28 refers to the quarter ended March 31, 2026, while the newer filing filed 2026-07-31 refers to the quarter ended June 30, 2026.
- In the signature block, the older filing filed 2026-04-28 is dated April 28, 2026, while the newer filing filed 2026-07-31 is dated July 31, 2026.
- Notes:
- The extracted text for the Risk Factors section contains other SEC filing items (Items 2 through 6 and signatures) in both versions.
- The comparison includes differences in subsequent sections beyond Item 1A Risk Factors because the provided excerpts include those sections.
AI-assisted comparison of two SEC filing sections. It describes wording and theme changes only, makes no materiality, legal, or investment judgement, and is not financial advice. Informational only — not financial advice.
Insider activity (SEC Form 4)
0 open-market purchases and 6 open-market sales by insiders in the last 90 days, of which we have read Form 4 filings through 2026-10-05. The 5 days since 2026-10-05 have not been checked yet.
- Last 30 days · read to 2026-10-050 buys · 2 sells ($2M) — 1 selling insider
- Last 90 days · read to 2026-10-050 buys · 6 sells ($5M) — 3 selling insiders
- Last 180 days · read to 2026-10-050 buys · 10 sells ($7M) — 5 selling insiders
Activity heuristic: net selling (a transparent product heuristic from the counts above, not a prediction or advice)
Most recent open-market transaction: 2026-09-28. Based on Form 4 filings read through 2026-10-05; anything filed since is not yet included.
View full insider trading history → View SEC Form 3/4/5 filingsAsk about CHE's insider activity →
Only open-market purchases (SEC code P) and sales (code S) are counted here. Option exercises, vesting/awards, gifts, and shares withheld for taxes are excluded — they are compensation or mechanical, not open-market conviction. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan) and are not necessarily bearish; open-market buying is not a recommendation to buy. Informational only — not financial advice.
U.S. House trading disclosures
U.S. House members publicly disclose their own, their spouse's, and dependent children's stock transactions under the STOCK Act. We hold 3 matched disclosures for CHE from U.S. House Clerk Periodic Transaction Report filings.
U.S. House trading disclosures →Institutional ownership (13F)
6 institutional 13F filers reported holding CHE as of 2026-06-30 (quarter-end position, filed within 45 days).
- Distinct 13F filers 6
- Reported shares held 2,071,345
- Reported value $964,708,302
reported quarterly holdings change (2026-03-31 → 2026-06-30): 0 new, 3 increased, 3 decreased, 0 exited. Change counts cover only managers that filed 13F reports in BOTH quarters, derived between two quarter-end snapshots — not same-day trades; a single manager is never said to have "bought" or "sold".
Institutional holdings are quarter-end long positions reported on SEC Form 13F-HR, filed up to 45 days after the quarter ends — they are delayed, are not real-time trades, exclude short positions and most non-US securities, and are not investment advice. Any increase/decrease is a reported change between two quarterly snapshots, not a same-day purchase or sale. These are quarter-end snapshots from the 13F filings on SEC EDGAR, filed within 45 days — not real-time, and any change is a difference between two quarterly reports, not a same-day trade. Informational only — not financial advice.
Ask about CHE's institutional holders → See what each manager we track holds →
Short interest (FINRA)
CHE had 653,250 shares of reported short interest as of the 2026-09-15 FINRA settlement date (delayed, bi-monthly; not real-time).
CHE had 5.00% of its shares outstanding sold short as of the 2026-09-15 FINRA settlement date (percent of FLOAT would be higher — float is not disclosed in the source). FINRA reported 5.4 days to cover at the same settlement.
- Reported short interest (shares) 653,250
- Short interest (% of shares outstanding) 5.00%
- Prior settlement (shares) 564,624
- Reported change 15.7%
- Days to cover (reported) 5.4
Reported to FINRA as of the 2026-09-15 settlement date. Short interest is reported to FINRA and published on a delayed, bi-monthly schedule (as of a settlement date, disseminated roughly eight business days later) — it is NOT real-time, does not cover every venue or all US trading, and is not a short-squeeze prediction or investment advice. Days-to-cover is the value FINRA reports; percent of float is not shown because the source file carries no share-count denominator — where a percent appears it is of shares OUTSTANDING, the larger base, and is therefore a floor on percent of float. Informational only — not financial advice.
Competitors & peers
- Amedisys (AMED)
- The Ensign Group (ENSG)
- Addus HomeCare (ADUS)
- Mr. Rooter (Neighborly)
- Benjamin Franklin Plumbing (Clockwork Home Services)
AI-enriched competitor set. Linked names are companies covered by stocks-llm; other named peers are shown for reference only.
Compare CHE vs…
Frequently asked questions
What does Chemed Corporation (CHE) do?
Chemed Corporation operates through two primary business segments: VITAS Healthcare, which is a provider of end-of-life hospice care, and Roto-Rooter, which offers plumbing and drain cleaning services. VITAS provides hospice services in various states across the U.S., while Roto-Rooter provides residential and commercial plumbing services.
What sector is Chemed Corporation (CHE) in?
Chemed Corporation (CHE) is classified in the Health Care sector. Its industry is Diversified Services and Healthcare. It trades on NYSE.
Does CHE pay a dividend?
Yes — Chemed Corporation (CHE) pays a dividend, with an indicated yield of about 0.56% and at least 18 years of non-decreasing per-share dividends (SEC EDGAR XBRL) — we do not hold the year before it, so the real streak may be longer (market data, as of 2026-09-03). Informational only — not financial advice.
Who are Chemed Corporation's (CHE) competitors?
Notable peers of Chemed Corporation (CHE) include Amedisys, The Ensign Group, Addus HomeCare, Mr. Rooter (Neighborly) and Benjamin Franklin Plumbing (Clockwork Home Services). This peer set is informational only — not financial advice.
Has there been recent U.S. House stock trading in CHE?
Yes — we hold 3 matched STOCK Act disclosures for CHE from U.S. House Clerk Periodic Transaction Report filings. These are legally-required disclosures (often filed 30–45 days after the trade), may belong to a U.S. House member, their spouse, or a dependent child, and are not an indicator of company performance or investment advice.
Is Chemed Corporation (CHE) overbought or oversold right now?
Chemed Corporation (CHE) is currently neither overbought nor oversold — its 14-day RSI (a 0–100 momentum gauge) is 42, in the neutral middle (as of 2026-10-09). RSI describes recent price momentum, not a forecast — informational only, not financial advice.
Where does stocks-llm's data on CHE come from?
Fundamentals come from SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest; prices are market data, as of 2026-09-03; company filings and profile facts come from SEC EDGAR. All figures are delayed daily-close data shown with their as-of date — informational only, not financial advice.
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-09.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.